BIOMAT Database Logo BIOMAT Database Logo

N-succinimidyl ester of ofloxacin--a novel prodrug. 1995

J Dobias, and M Uher, and A Korenová, and J Brtko, and A Belicová, and P Foltínová, and L Ebringer
Institute of Molecular and Subcellular Biology, Comenius University, Bratislava, Slovak Republic.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D015242 Ofloxacin A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. DL-8280,DR-3355,Hoe-280,ORF-28489,Ofloxacin Hydrochloride,Ofloxacine,Ru-43280,Tarivid,DL 8280,DL8280,DR 3355,DR3355,Hoe 280,Hoe280,ORF 28489,ORF28489,Ru 43280,Ru43280

Related Publications

J Dobias, and M Uher, and A Korenová, and J Brtko, and A Belicová, and P Foltínová, and L Ebringer
N-9-fluorenylmethoxycarbonylpyroglutamate. Preparation of the acid, chloride and succinimidyl ester.
April 1994, International journal of peptide and protein research,
J Dobias, and M Uher, and A Korenová, and J Brtko, and A Belicová, and P Foltínová, and L Ebringer
Effects of aluminium-containing antacid on bioavailability of ofloxacin following oral administration of pivaloyloxymethyl ester of ofloxacin as prodrug.
June 1993, Biological & pharmaceutical bulletin,
J Dobias, and M Uher, and A Korenová, and J Brtko, and A Belicová, and P Foltínová, and L Ebringer
Development of a novel sulfonate ester-based prodrug strategy.
January 2016, Bioorganic & medicinal chemistry letters,
J Dobias, and M Uher, and A Korenová, and J Brtko, and A Belicová, and P Foltínová, and L Ebringer
Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents.
January 1990, Bioconjugate chemistry,
J Dobias, and M Uher, and A Korenová, and J Brtko, and A Belicová, and P Foltínová, and L Ebringer
N-sulfonyl imidates as a novel prodrug form for an ester function or a sulfonamide group.
November 1988, Journal of medicinal chemistry,
J Dobias, and M Uher, and A Korenová, and J Brtko, and A Belicová, and P Foltínová, and L Ebringer
Enzyme labeling in steroid enzyme immunoassays. Comparison of the p-nitrophenyl ester and N-succinimidyl ester methods.
September 1991, Chemical & pharmaceutical bulletin,
J Dobias, and M Uher, and A Korenová, and J Brtko, and A Belicová, and P Foltínová, and L Ebringer
A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester.
March 2009, Journal of immunological methods,
J Dobias, and M Uher, and A Korenová, and J Brtko, and A Belicová, and P Foltínová, and L Ebringer
Dicesium N-succinimidyl 3-(undecahydro-closo-dodecaboranyldithio)propionate, a novel heterobifunctional boronating agent.
April 1985, Journal of medicinal chemistry,
J Dobias, and M Uher, and A Korenová, and J Brtko, and A Belicová, and P Foltínová, and L Ebringer
[Study on 5-carboxyfluorescein N-succinimidyl ester in detecting the degree of cross-linked allogenic tissue].
August 2010, Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi,
J Dobias, and M Uher, and A Korenová, and J Brtko, and A Belicová, and P Foltínová, and L Ebringer
N-succinimidyl methoxyphenylacetic acid ester, an amine-directed chiral derivatizing reagent suitable for enzymatic scale resolutions.
April 1989, Analytical biochemistry,
Copied contents to your clipboard!